参考文献/References:
[1] 唐任光, 韦叶生, 陈宏明, 等.食管癌患者血清细胞因子和急性时相反应蛋白的变化及其临床意义[J].现代检验医学杂志,2008, 23(1):11-14. TANG Renguang, WEI Yesheng, CHEN Hongming, et al. Study on the changes of serum cytokine and acute phase reaction protein(APRP)in patients with esophageal cancer and its clinical sinificance[J]. Journal of Modern Laboratory Medicine,2008，23(1):11-14.
[2] 肖小平, 张熊, 秦光明.食管癌和良性食管疾病患者血浆miRNA-21和miRNA-143检测的临床应用研究[J].现代检验医学杂志,2017,32(4):72-75，139. XIAO Xiaoping, ZHANG Xiong, QIN Guangming. Clinical research of detecting plasma miRNA-21 and miRNA-143 for identifying early esophageal cancer and benign esophageal diseases[J]. Journal of Modern Laboratory Medicine,2017,32(4):72-75，139.
[3] 邱巍, 胡威, 赵建江, 等.江苏宿迁地区汉族人群DNMT3B基因启动子区-149C＞T和-579G＞T多态性与食管癌易感性的分析[J].现代检验医学杂志,2018,33(2):28-30. QIU Wei, HU Wei, ZHAO Jianjiang, et al. Study on the promoter region-149C＞T and-579G＞T polymorphism of DNMT3B with genetic susceptibility to esophageal cancer of han population in Jiangsu Suqian[J].Journal of Modern Laboratory Medicine,2018,33(2):28-30.
[4] ALLEMANI C, MATSUDA T, DI CARLO V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet (London, England), 2018, 391(1125): 1023-1075.
[5] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA：A Cancer Journal for Clinicians, 2018, 68(6): 394-424.
[6] SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics,2019[J]. CA：A Cancer Journal for Clinicians, 2019, 69(1): 7-34.
[7] CHEN Wanqing. Cancer statistics: updated cancer burden in China[J]. Chinese Journal of Cancer Research, 2015, 27(1): 1.
[8] CHEN Wanqing, SUN Kexin, ZHENG Rongshou, et al. Cancer incidence and mortality in China, 2014[J]. Chinese Journal of Cancer Research, 2018, 30(1): 1-12.
[9] 景文江, 郭翠萍, 马军, 等.miR-144和lncRNA DNAJC3-AS1在乳腺癌组织中的表达及其在乳腺癌细胞MCF-7化疗耐药中的作用[J].中国肿瘤生物治疗杂志,2020,27(2):177-183. JING Wenjiang, GUO Cuiping, MA Jun, et al. Expression of miR-144 and lncRNA DNAJC3-AS1 in breast cancer tissues and their roles in chemotherapy resistance of breast cancer MCF-7 cells[J].Chinese Journal of Cancer Biotherapy,2020,27(2):177-183.
[10] 梁日东．长链非编码RNADNAJC3-AS1在骨肉瘤中的表达和功能探讨[D].广州：南方医科大学，2019． LIANG Ridong. Expression and functional study of long non-coding RNADNAJC3-AS1 in osteosarcoma[D].Guangzhou:Southern Medical University,2019.
[11] 吴璇, 邝钢, 任利兵, 等.长链非编码RNA ZNF667-AS1在食管鳞状细胞癌组织中的表达及其DNA甲基化状态的研究[J]．肿瘤防治研究,2018,45(12):976-980. WU Xuan, KUANG Gang, REN Libing, et al. Expression and DNA methylation status of long non-coding RNA ZNF667-AS1 in esophageal squamous cell carcinoma tissues[J]. Cancer Research on Prevention and Treatment,2018,45(12):976-980.
[12] 李国良,朱明闯,熊鹏,等.长链非编码RNA在食管癌中的研究进展[J]. 实用医学杂志,2018,34(24):4015-4018. LI Guoliang, ZHU Mingchuang, XIONG Peng, et al. Research progress of long non-coding RNA in esophageal cancer[J]. The Journal of Practical Medicine,2018,34(24):4015-4018.
相似文献/References:
[1]张 振,李 力,徐翠香,等.血清TAM和Cyfra21-1检测在食管癌诊断和化疗疗效判定中的价值[J].现代检验医学杂志,2015,30(04):150.[doi:10.3969/j.issn.1671-7414.2015.04.046]
ZHANG Zhen,LI Li,X(¨overU)Cui-xiang,et al.Value of Detecting Serum TAM and Cyfra21-1 Levels in the Diagnosis
and Chemotherapeutic Efficacy of Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):150.[doi:10.3969/j.issn.1671-7414.2015.04.046]
[2]朱卫华,刘继斌.血浆相关基因甲基化在食管癌复发中的临床价值[J].现代检验医学杂志,2016,31(04):93.[doi:10.3969/j.issn.16717-414.2016.04.025]
ZHU Wei-hua,LIU Ji-bin.Clinical Significance of Promoter Hypermethylation of Esophageal
Squamous Cell Carcinoma(ESCC)in Plasma[J].Journal of Modern Laboratory Medicine,2016,31(02):93.[doi:10.3969/j.issn.16717-414.2016.04.025]
[3]肖小平,张 熊sub>a,秦光明b.食管癌和良性食管疾病患者血浆miRNA-21和miRNA-143检测的临床应用研究[J].现代检验医学杂志,2017,32(04):72.[doi:10.3969/j.issn.1671-7414.2017.04.020]
XIAO Xiao-ping,ZHANG Xionga,QIN Guang-mingb.Clinical Research of Detecting Plasma MiRNA-21 and MiRNA-143
for Identifying Early Esophageal Cancer and Benign Esophageal Diseases[J].Journal of Modern Laboratory Medicine,2017,32(02):72.[doi:10.3969/j.issn.1671-7414.2017.04.020]
[4]邱 巍,胡 威,赵建江,等.江苏宿迁地区汉族人群DNMT3B基因启动子区-149C>T和-579G>T多态性与食管癌易感性的分析[J].现代检验医学杂志,2018,33(02):28.[doi:10.3969/j.issn.1671-7414.2018.02.001]
QIU Wei,HU Wei,ZHAO Jian-jiang,et al.Study on the Promoter Region -149C>T
and -579G>T Polymorphism of DNMT3B with Genetic Susceptibility
to Esophageal Cancer of Han Population in Jiangsu Suqian[J].Journal of Modern Laboratory Medicine,2018,33(02):28.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]陈 津,彭 伟,崔兆磊,等.食管癌放疗患者血清涎液化糖链抗原水平检测在预测放射性肺炎的风险评估[J].现代检验医学杂志,2020,35(03):126.[doi:10.3969/j.issn.1671-7414.2020.03.034]
CHEN Jin,PENG Wei,CUI Zhao-lei,et al.Serum KL-6 Predicts the Risk of Pneumonitis Induction after
Radiotherapy of Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(02):126.[doi:10.3969/j.issn.1671-7414.2020.03.034]
[6]高红敏,杨红英,刘 鑫.血清中 microRNA-106b 对宫颈癌患者的早期诊断及预后预测价值[J].现代检验医学杂志,2020,35(06):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
GAO Hong-min,YANG Hong-ying,LIU Xin.Value Analysis of Serum microRNA-106b in Early Diagnosis ofCervical Cancer[J].Journal of Modern Laboratory Medicine,2020,35(02):85.[doi:doi:10.3969/j.issn.1671-7414.2020.06.020]
[7]朱 涛,王 伟a,吴和刚b.胃癌组织中FOXP1和FOXQ1的表达水平与临床病理特征及预后关系[J].现代检验医学杂志,2021,36(04):68.[doi:10.3969/j.issn.1671-7414.2021.04.015]
ZHU Tao,WANG Weia,WU He-gangb.Expression of FOXP1 and FOXQ1 in Gastric Cancer and TheirRelationship with Clinicopathological Features and Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(02):68.[doi:10.3969/j.issn.1671-7414.2021.04.015]
[8]朱 娇a,孙国才b,刘素荣a,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
ZHU Jiaoa,SUN Guo-caib,LIU Su-ronga,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(02):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[9]荣 蓉a,古 颖a,高 翔a,等.前列腺癌组织肝激酶B1，Rab鸟嘌呤核苷酸交换因子-5mRNA表达水平与临床病理特征和预后的相关性研究[J].现代检验医学杂志,2021,36(06):1.[doi:10.3969/j.issn.1671-7414.2021.06.001]
RONG Rong,GU Ying,GAO Xiang,et al.Correlation between the Expression Levels of Liver Kinase B1, Rab Guanine Nucleotide Exchange Factor-5 mRNA in Prostate Cancer Tissues and Its Clinicopathological Characteristics and Prognosis[J].Journal of Modern Laboratory Medicine,2021,36(02):1.[doi:10.3969/j.issn.1671-7414.2021.06.001]
[10]王英英,朱 娇.三阴性乳腺癌患者血清miR-146a，miRlet-7a水平表达与临床病理特征和化疗疗效的相关性研究[J].现代检验医学杂志,2021,36(06):60.[doi:10.3969/j.issn.1671-7414.2021.06.012]
WANG Ying-ying,ZHU Jiao.Correlation of Serum miR-146a and miR let-7a Expression with Clinicopathological Characteristics and Chemotherapy Efficacy in Patients with Triple Negative Breast Cancer[J].Journal of Modern Laboratory Medicine,2021,36(02):60.[doi:10.3969/j.issn.1671-7414.2021.06.012]